Born On The Battlefield: AcelRx Awaits FDA Ruling On Device That Delivers Potent Opioid To Wounded Soldiers
AcelRx CFO Shares Update On DoD Relationship And More After FDA Accepted NDA For DSUVIA
Exclusive: AcelRx Pharma Execs Discuss Stock Performance, Catalysts And Financial Position
AcelRx: Replacing Morphine With Department Of Defense Funding